Table 4. Methylation in fifteen significantly differentially methylated probes in NR3C1.

Probe	Positiona	Strand	Location	Intron number	Casesb	Controlsc	Delta-betad	p	qvale
cg15645634	142783639	F	Intron	8	0.0356	0.0261	0.0095	8.31E-06	0.000189
cg14558428	142784982	R	Intron	8	0.0396	0.0314	0.0082	0.000396	0.004514
cg17860381	142783569	R	Intron	8	0.0412	0.0336	0.0076	0.00306	0.015499
cg26464411	142784222	R	Intron	8	0.0556	0.0465	0.0091	0.00406	0.017017
cg18019515	142783385	R	Intron	8	0.0235	0.0192	0.0043	0.00437	0.017388
cg18146873	142782827	F	Intron	8	0.0279	0.0211	0.0068	0.00550	0.018472
cg07733851	142781498	R	Intron	8	0.375	0.407	−0.032	0.00573	0.018648
cg25535999	142757312	R	Intron	7	0.922	0.935	−0.013	0.0110	0.030167
cg18594054	142623446	R	Upstream		0.926	0.939	−0.013	0.0144	0.035689
cg04097219	142629749	F	Upstream		0.972	0.978	−0.006	0.0177	0.040303
cg06770322	142851098	F	Downstream		0.960	0.966	−0.006	0.0279	0.051311
cg23273257	142658828	R	5′UTR		0.977	0.982	−0.005	0.0279	0.051315
cg21702128	142784721	F	Intron	8	0.0516	0.0473	0.0043	0.0306	0.053550
cg25781210	142610141	F	Upstream		0.959	0.967	−0.008	0.0429	0.064421
cg06521673	142782072	R	Intron	8	0.0227	0.0201	0.0026	0.0435	0.064851

Methylation in fifteen significantly differentially methylated probes (reported as beta-values) in NR3C1 on chromosome 5.

^aHuman genome build 37.

^bCS patients.

^cControls.

^dDifference in methylation between cases and controls.

^eq-values from multiple correction analysis using a 10% FDR.